(Q46915747)

26 December 2017

title

Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials (English)

1 reference

26 December 2017

1 reference

1 reference

Clark J

1

1 reference

26 December 2017

Schall R

series ordinal

2

1 reference

26 December 2017

publication date

1 September 2007

1 reference

26 December 2017

published in

Allergy

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1023-1028

1 reference

26 December 2017

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01469.X

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01469.X

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01469.X

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01469.X

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01469.X

10.1111/J.1398-9995.2007.01469.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017